Curis (CRIS) Outpaces in Q3; Roth Affirms 'Buy' Rating Ahead of ASH
Tweet Send to a Friend
Roth Capital reaffirms Curis (Nasdaq: CRIS) with a Buy rating and $5 price target following Q3 results and update issued ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
